Skip to main content
. 2022 Jan 6;2:807123. doi: 10.3389/fresc.2021.807123

Table 1.

Relationship between Klotho levels and indices of physical function and health.

Reference Study design Population Sample and technique Key findings
Amaro-Gahete et al. (123) Cross-sectional study in the FIT-AGING study cohort. Middle-aged sedentary adults (n = 74, 35 men, age 53.7 ± 5.1 years) -Plasma
-ELISA (Demeditec, Kiel, Germany)
-sKlotho is positively associated with lean mass index after controlling for age and sex.
Amaro-Gahete et al. (122) Cross-sectional study in the FIT-AGING study cohort. Middle-aged sedentary adults (n = 74, 35 men, age 53.7 ± 5.1 years) -Plasma
-ELISA (Demeditec, Kiel, Germany)
-sKlotho is positively associated with VO2max, knee extension peak torque, and hand grip strength.
Baldan et al. (125) Cross-sectional study. β-thalassemia major (ß-TM) patients (n = 106, 43 men, age 38.6 ± 6.5 years) and healthy blood donors (n = 95, 70 men, age 40.9 ± 7.8 years) -Plasma
-ELISA (IBL Ltd., Takasaki, Japan)
-sKlotho levels are lower in patients with ß-TM compared to healthy controls.
-Up to an estimated sKlotho's threshold value of 580 ± 149 pg/mL, a weak linear correlation was observed between sKlotho and normalized hand-grip strength in ß-TM patients.
-No correlation was found for Klotho values above 580 pg/mL.
Chalhoub et al. (126) -Prospective study in the Health, Aging, and Body Composition (Health ABC) study cohort.
-Patients were followed up for a median of 5 years.
Well-functioning older adults (n = 2,776, aged 70 to 79 years) were divided into sKlotho quartiles: quartile 1: 320.6–437.3 pg/mL; quartile 2: 521.6–592.1 pg/mL; quartile 3: 670.1–756.2 pg/mL; and quartile 4: 887.7–1186.4 pg/mL. -Serum
-ELISA (IBL Ltd., Takasaki, Japan)
-No differences were observed between quartiles on gait speed, grip strength, or appendicular lean mass.
-sKlotho levels are not associated with bone mineral density, bone loss, or fracture risk in older individuals.
Crasto et al. (7) Cross-sectional study in the Invecchiare in Chianti (InCHIANTI) study cohort. Population-based sample of 802 adults aged 65 years and older divided into sKlotho tertiles: tertile 1: <575 pg/mL; tertile 2: 575–763 pg/mL; and tertile 3: >763 pg/mL -Plasma
-ELISA (IBL Ltd., Takasaki, Japan)
-Lower levels of sKlotho were associated with older age, lower SPPB score, lower cognitive function, and higher ADL disability.
-Low sKlotho was associated with ADL disability after adjusting for age, education, SPPB, congestive heart failure, and diabetes.
Dote-Montero et al. (127) Cross-sectional study in the FIT-AGING study cohort. Middle-aged sedentary adults (n = 73, 34 men, age 53.8 ± 5.1 years) -Plasma
-ELISA (Demeditec, Kiel, Germany)
-sKlotho was positively associated with DHEAS in men but not women, but this disappeared after adjusting for age.
-sKlotho was positively associated with testosterone in both men and women.
-The association between sKlotho and testosterone disappeared after adjusting for age in men, but not in women.
Fukasawa et al. (128) Cross-sectional study. Hemodialysis patients (n = 77, 52 men, median age = 67.0 years, IQR = 60.0–73.0 years) -Plasma
-ELISA (IBL Ltd., Takasaki, Japan)
No significant correlation between sKlotho levels and abdominal muscle area or creatinine production.
Matsubara et al. (129) Cross-sectional study. Healthy and postmenopausal women (n = 69, aged 60 ± 1) -Plasma
-ELISA (IBL Ltd., Tokyo, Japan)
-sKlotho and carotid arterial compliance were positively correlated after adjusting for age, pulse pressure, and BMI.
-sKlotho is positively correlated with VO2 at VT after adjusting for age and BMI.
Mostafidi et al. (130) -Cross-sectional study.
-Blood samples were obtained after an 8 hour fast the morning following an afternoon training session.
Healthy male football players (n = 30, aged 18–22 years) who were performing daily morning and evening exercise training and healthy non-athlete male controls (n = 28, age 18–27 years). -Plasma
-ELISA (Hangzhou Eastgbiopharm Co., Ltd., Hangzhou, China)
-sKlotho levels are significantly higher in football players compared to healthy controls with normal physical activity levels.
Patel et al. (131) Cross-sectional study. Never smokers (n = 13, 10 men, age 65 ± 8), smokers with normal spirometry (n = 13, 5 men, age 51 ± 7), and COPD patients (n = 61, 38 men, age 64 ± 10). -Vastus lateralis protein expression and serum.
-ELISA (IBL Ltd., Japan)
-Immunohistochemistry (rabbit anti-Klotho antibody [diluted 1:100], Aviva Systems Biology, San Diego, CA, USA)
-Quadriceps Klotho levels were lower in smokers compared to non-smokers.
-Quadriceps Klotho levels were higher in patients with low fat free mass index and low quadriceps strength.
-sKlotho had an independent association with quadriceps strength but did not relate to quadriceps Klotho levels.
-Klotho protein was localized to the muscle fiber membrane and associated with centralized nuclei.
Patel et al. (131) Mice exposed to air or 4% cigarette smoke for 2 hours/day, 5 days/week, for 77 weeks were evaluated for Klotho expression in the context of muscle damage induced by electroporation. Female C57BL/6 mice, 3–4 months of age divided into sham (n = 9) or cigarette smoke (n = 19). Gastrocnemius protein expression
-ELISA (IBL Ltd., Japan)
-Immunohistochemistry (rabbit anti-Klotho antibody [diluted 1:100], Aviva Systems Biology, San Diego, CA, USA)
-Significant Klotho protein expression present in damaged skeletal muscle tissue, but not healthy tissue.
-Klotho co-localized to both the plasma membrane and to centralized nuclei.
-↓ in gastrocnemius Klotho protein levels in mice exposed to smoke compared to sham.
Phelps et al. (3) Klotho deficient mice were compared to transgenic Klotho overexpressing mice and wildtype mice for strength and running endurance. Klotho deficient mice (Klotho homozygous males, C57BL/6), transgenic Klotho overexpressing mice (EFmKL46, homozygous, males and females, C57BL/6), and wildtype mice. -Kidney and Gastrocnemius mRNA expression
-RT-qPCR analysis
-Gastrocnemius Klotho mRNA expression level in EFmKL46 mice was 70-fold higher compared to wildtype mice.
-Klotho expression was not detected in the gastrocnemius of Klotho deficient mice.
-Forelimb grip force 53% and 51% lower in Klotho deficient mice compared to wildtype and EFmKL46 mice, respectively.
-Klotho deficient mice spent 66% and 62% less time running than wildtype and EFmKL46 mice, respectively.
Polat et al. (132) Cross-sectional study. Frail (n = 45, 14 men, age 79.4 ± 6.9 years) and non-frail (n = 44, 17 men, age 72.7 ± 4.5 years) older adults. -Serum
-ELISA (IBL Ltd., Takasaki, Japan)
-No significant difference in sKlotho between frail and non-frail patients.
-No significant correlation between sKlotho and frail score.
Rosa et al. (133) Cross-sectional study. Master endurance runners (n = 18, age 53 ± 8.2 years), master sprinters (n = 13, age 50 ± 8.9 years), untrained healthy young (n = 17, age 22.7 ± 3.9 years), and untrained middle-aged (n = 12, age 45.5 ± 9.8 years) men. -Serum
-ELISA (IBL Ltd., Japan)
-sKlotho levels were higher in master sprinters than master endurance runners and untrained middle-aged men.
-sKlotho levels were similar between young untrained men and master sprinters.
-sKlotho levels were higher in young untrained men than master endurance runners and untrained middle-aged men.
Sanz et al. (134) -Prospective study.
-Patients were followed up for 6 months.
Older adults living in nursing homes in Gipuzkoa, Spain (n = 103, 30 men, age 84.7 ± 6.96 years) -Serum
-ELISA (IBL Ltd., Gunma, Japan)
-Low sKlotho levels were associated with a lower score in the psychological component of the Tilburg Frailty Indicator, greater dependence in activities of daily living, and more falls during the 6-month follow-up.
Semba et al. (8) -Prospective study in the Invecchiare in Chianti (InCHIANTI) study cohort.
-Patients were followed up for 6 years.
Population-based sample of 804 adults aged 65 years and older. -Plasma
-ELISA (IBL Ltd., Takasaki, Japan)
-sKlotho was positively associated with grip strength at a threshold of <681 pg/mL after adjusting for age, sex, education, smoking, physical activity, cognition, and chronic diseases.
Semba et al. (9) -Prospective study in the Health, Aging, and Body Composition (Health ABC) study cohort.
-Patients were followed up for 4 years.
Well-functioning older adults (n = 2,734, aged 71 to 80 years) were divided into sKlotho tertiles: tertile 1: <536 pg/mL; tertile 2: 536–747 pg/mL; and tertile 3: >747 pg/mL. -Plasma
-ELISA (IBL Ltd., Takasaki, Japan)
-The highest tertile of sKlotho had higher knee extension strength compared with those in the lowest tertile after adjusting for age, sex, race, smoking, study site, inflammatory markers, and diabetes.
-The highest tertile of sKlotho had less of a decline in knee strength over 4 years of follow-up compared with those in the lowest tertile after adjusting for the same covariates above.
Shardell et al. (11) -Prospective study in the Invecchiare in Chianti (InCHIANTI) study cohort.
-Patients were followed up for 6 years.
Population-based sample of 860 adults aged 55 years and older split by sKlotho median (669 pg/mL) -Plasma
-ELISA (IBL Ltd., Takasaki, Japan)
-Higher sKlotho levels were associated with higher average SPPB scores after adjustment for covariates.
Shardell et al. (10) -Prospective study in the Invecchiare in Chianti (InCHIANTI) study cohort.
-Patients were followed up for 3 years.
Population-based sample of 774 adults aged 65 years and older split by sKlotho median (660 pg/mL) -Plasma
-ELISA (IBL Ltd., Takasaki, Japan)
-Higher sKlotho levels were associated with lower odds of frailty after adjustment for covariates.
-Higher sKlotho was particularly associated with lower odds of exhaustion.
Valenzuela et al. (124) -Prospective study in an elderly dialysis cohort.
-All-cause mortality was registered 18 months later.
ESRD male dialysis patients (n = 30, age 71 ± 9 years) split by sKlotho median (369 pg/mL) -Plasma
-ELISA (IBL Ltd., Japan)
Lower sKlotho levels were associated with higher risk of having low handgrip strength and low performance on the 6-min walk test and the sit-to-stand test.

ELISA, enzyme-linked immunosorbent assay; sKlotho, soluble Klotho; VO2max, maximal oxygen uptake; IBL, Immuno-Biological Laboratories; ß-TM, β-thalassemia major; SPPB, short physical performance battery; ADL, activities of daily living; DHEAS, dehydroepiandrosterone sulfate; BMI, body mass index; VO2 at VT, oxygen consumption at the point of ventilatory threshold; RT-qPCR, reverse transcription quantitative polymerase chain reaction.